Cargando…

Improvement of Certolizumab Fab′ properties by PASylation technology

Certolizumab pegol is a Fab′ antibody fragment for treatment of rheumatoid arthritis and Crohn’s disease which is conjugated to a 40 kDa PEG molecule in order to increase the protein half-life. PEGylation may have disadvantages including immunogenicity, hypersensitivity, vacuolation, decreased bindi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazaheri, Somayeh, Talebkhan, Yeganeh, Mahboudi, Fereidoun, Nematollahi, Leila, Cohan, Reza Ahangari, Mirabzadeh Ardakani, Esmat, Bayat, Elham, Sabzalinejad, Masoumeh, Sardari, Soroush, Torkashvand, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595094/ https://www.ncbi.nlm.nih.gov/pubmed/33116155 http://dx.doi.org/10.1038/s41598-020-74549-0

Ejemplares similares

Extension of human GCSF serum half-life by the fusion of albumin binding domain
por: Nikravesh, Fatemeh Yadavar, et al.
Publicado: (2022)

Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology
por: Aghaabdollahian, Safieh, et al.
Publicado: (2019)

Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
por: Komijani, Samira, et al.
Publicado: (2021)

High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation
por: Mendler, Claudia T, et al.
Publicado: (2014)

Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties
por: Torkashvand, Fatemeh, et al.
Publicado: (2023)

Optimization of EnBase Fed-Batch Cultivation to Improve Soluble Fraction Ratio of α-Luffin Ribosome Inactivating Protein
por: Barkhordari, Farzaneh, et al.
Publicado: (2018)

Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo
por: Peplau, Emanuel, et al.
Publicado: (2021)

Expression of granulocyte colony stimulating factor (GCSF) in Hansenula polymorpha
por: Talebkhan, Yeganeh, et al.
Publicado: (2016)

Recombinant anti-human epidermal growth factor receptor type 2 single-chain variable fragment-alpha-luffin fusion protein as a putative immunotoxin against human epidermal growth factor receptor type 2-positive breast cancer cells: an experimental research
por: Damough, Shadi, et al.
Publicado: (2023)

MALDI-MS: a Rapid and Reliable Method for Drug-to-Antibody Ratio Determination of Antibody-Drug Conjugates
por: Abedi, Mehri, et al.
Publicado: (2019)

Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar
por: Fazel, Ramin, et al.
Publicado: (2019)

Effect of Cysteamine on Cell Growth and IgG(4) Production in Recombinant Sp2.0 Cells
por: Jahandar, Hoda, et al.
Publicado: (2015)

Induction of Immunogenic Response in BALB/c Mice by Live and Killed Form of Recombinant Lactococcus lactis Displaying EG95 of Echinococcus granulosus
por: Ebrahimzadeh, Fatemeh, et al.
Publicado: (2021)

First In-Human Medical Imaging with a PASylated (89)Zr-Labeled Anti-HER2 Fab-Fragment in a Patient with Metastatic Breast Cancer
por: Richter, Antonia, et al.
Publicado: (2020)

Computational and Experimental Evaluation of Linker Peptides and Thioredoxin Fusion Tag in CD20-rituximab Specific Interactions
por: Damough, Shadi, et al.
Publicado: (2023)

Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate
por: Oghalaie, Akbar, et al.
Publicado: (2022)

Novel Descriptors Derived from the Aggregation Propensity of Di- and Tripeptides Can Predict the Critical Aggregation Concentration of Longer Peptides
por: Zanganeh, Saeed, et al.
Publicado: (2021)

Design of Small Molecules with HIV Fusion Inhibitory Property Based on Gp41 Interaction Assay
por: Sardari, Soroush, et al.
Publicado: (2013)

Scale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator (mt-PA) in rats
por: Raigani, Mozhgan, et al.
Publicado: (2017)

Efficacy and antitumor activity of a mutant type of interleukin 2
por: Dehghan, Rada, et al.
Publicado: (2022)

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
por: Schlapschy, Martin, et al.
Publicado: (2013)

PASylated Thymosin α1: A Long-Acting Immunostimulatory Peptide for Applications in Oncology and Virology
por: Binder, Uli, et al.
Publicado: (2020)

PASylated Urate Oxidase Enzyme: Enhancing Biocatalytic Activity, Physicochemical Properties, and Plasma Half-Life
por: Najjari, Abbas, et al.
Publicado: (2022)

Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach
por: Beig Parikhani, Arezoo, et al.
Publicado: (2022)

Effects of Peptone Supplementation in Different Culture Media on Growth, Metabolic Pathway and Productivity of CHO DG44 Cells; a New Insight into Amino Acid Profiles
por: Davami, Fatemeh, et al.
Publicado: (2015)

Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody
por: Torkashvand, Fatemeh, et al.
Publicado: (2015)

Expression of a Novel Chimeric Truncated t-PA in CHO Cells Based on in Silico Experiments
por: Davami, Fatemeh, et al.
Publicado: (2010)

Cloning and expression of Aspergillus flavus urate oxidase in Pichia pastoris
por: Fazel, Ramin, et al.
Publicado: (2014)

Quantitative Proteomic Analysis of Cellular Responses to a Designed Amino Acid Feed in a Monoclonal Antibody Producing Chinese Hamster Ovary Cell Line
por: Torkashvand, Fatemeh, et al.
Publicado: (2018)

Direct Affinity Purification of Long‐Acting PASylated Proteins with Therapeutic Potential Using L‐Prolinamide for Mild Elution
por: Schilz, Jonas, et al.
Publicado: (2022)

Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)

Periplasmic Expression of a Novel Human Bone Morphogenetic Protein-7 Mutant in Escherichia coli
por: Nematollahi, Leila, et al.
Publicado: (2012)

Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007)

The Inhibitory Effect of Mouse Gastric DNA on Amplification of Helicobacter pylori Genomic DNA in Quantitative PCR
por: Alikhani, Mehdi, et al.
Publicado: (2019)

In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes
por: Akbari, Elahe, et al.
Publicado: (2021)

5. Certolizumab Pegol for RA in pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)

Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells
por: Moazzami, Reza, et al.
Publicado: (2021)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Khan, Abdul, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tpouiu4h63b6qpaeknrkqdfoks